Chief Financial and Business Officer · Tenaya Therapeutics, Inc. (TNYA)

Leone Patterson

A named executive officer of Tenaya Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,364,989

Salary $349,528Stock awards $182,700

FY2023: $1,273,581

3rd of 3 named executive officers at Tenaya Therapeutics by FY2024 total.

3 named officers on file for Tenaya Therapeutics, FY2024

Leone Patterson’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tenaya Therapeutics’s whole pay program stands against its peers

  • Tenaya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TNYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 17, 2025 (DEF 14A).

Free

Get Leone Patterson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Leone Patterson compensation by year

Tenaya Therapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Tenaya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024
Salary$216,477$445,609$455,000$349,528
Bonus—$0$0$0
Stock awards—$0$198,900$182,700
Option awards$3,414,160$781,202$455,297$831,337
Non-equity incentive$75,600$133,500$160,000$0
Pension and deferred compensation$0$0$0$0
All other$1,903$4,930$4,384$1,424
Total$3,708,140$1,365,241$1,273,581$1,364,989

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tenaya Therapeutics, Inc. DEF 14A filed April 17, 2025, accession 0001193125-25-084313, and prior-year filings.

How this page was built: the Tenaya Therapeutics, Inc. filed document, accession 0001193125-25-084313. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2025.

$3.7M
$1.4M
$1.3M
$1.4M
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU26,250$85,050—
RSU26,250$85,050—
Option35,750—$15.19
Option150,417—$3.06
Option132,812—$10.56

Per the Outstanding Equity Awards at Fiscal Year-End table in Tenaya Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Tenaya Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Faraz AliChief Executive Officer$3,281,901
Whittemore TingleyChief Medical Officer$1,661,145
Leone Patterson · this pageChief Financial and Business Officer$1,364,989

The full Tenaya Therapeutics compensation record

free company brief

This page is one person within Tenaya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tenaya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Leone Patterson's compensation dossier · One-time report. No refunds.